Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Acting IM Olanzapine in Agitated Schizophrenia
NCT00316238Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in schizophrenia, sponsored by Eli Lilly and Company. Started Apr 2006; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00316238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316238.